SHALMET

This brand name is authorized in Nigeria.

Active ingredients

The drug SHALMET contains one active pharmaceutical ingredient (API):

1
UNII 140QMO216E - METRONIDAZOLE
 

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

 
Read more about Methronidazole

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
04-6664 Solution for infusion Shalmet Infusion INJ_SOL 500 mg/100 mL 100 mL (in FFS Polyethylene container packed in BOPP bag) Solution for Infusion 31/07/2024
A11-100615 Tablet Shalmet 400 Tablets TAB 400 mg 10 x 10's (in blisters) Tablets 18 NF-PP-341724 SHALMET 400 TABLETS Metronidazole Tablets BP 400 mg Metronidazole BP 400 mg (EXCIPIENTS: Dibasic Calcium Phosphate Dihydrate BP, Maize Starch BP, Sodium Benzoate BP, Sodium Starch Glycolate BP, Colloidal Anhydrous Silica BP, Purified Talc BP, Magnesium Stearate BP, Polyvinyl Alcohol BP, Glycerol Monostearate USP/NF, Polysorbate 80 BP, Triacetin BP, Modified Starch USP/NF, Colour: Yellow Iron Oxide USP/NF, Lake Quinoline Yellow, Lake Sunset Yellow and Titanium Dioxide BP) A11-100615 Drugs Nigerian Products 10X10TABLETS POM 1 7/10/2023 SHALINA HEALTHCARE NIGERIA LIMITED, 19 Fatai Atere Way, Matori, Mushin 18183973 theophilus.adimoha@shalina.com SHALINA HEALTHCARE NIGERIA LTD., Block 3B, Westerner Industrial Avenue, Off Lagos-Ibadan Expressway, Isheri, IFO Local Government Area, Ogun State, Nigeria., Nigeria 21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01XD01 Metronidazole J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives
Discover more medicines within J01XD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database 04-6664, A11-100615

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.